… We have approved   [ Approval Letter ]

… Whole Blood and blood components

… Convalescent Plasma, High Titer, Anti-SARS-CoV-2 (Whole Blood-derived)

… and Apheresis Convalescent Plasma

… Indication:

Treatment of COVID-19 in patients with immunocompromise-immunosuppressive disease/process

or receiving immunosuppressive treatments

at risk of severe disease progression

in either the inpatient or outpatient setting  [ FDA ]

 

              Approval Letter

 

Share: